These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 4383958

  • 21. Proceedings: Pharmacology of the adrenergic mechanism.
    Pfeifer AK.
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
    [No Abstract] [Full Text] [Related]

  • 22. THE CLINICAL PHARMACOLOGY OF POSTGANGLIONIC SYMPATHETIC BLOCKING AGENTS.
    ABRAMS WB, POCELINKO R, MOE RA, BATES H, HANAUER L, CAMACHO S.
    Dis Chest; 1965 Aug; 48():178-86. PubMed ID: 14333651
    [No Abstract] [Full Text] [Related]

  • 23. Catecholamines.
    Axelrod J, Weinshilboum R.
    N Engl J Med; 1972 Aug 03; 287(5):237-42. PubMed ID: 4402575
    [No Abstract] [Full Text] [Related]

  • 24. RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE.
    BRODIE BB.
    Circulation; 1963 Nov 03; 28():970-86. PubMed ID: 14085298
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antihypertensive drugs that alter adrenergic function.
    Weinshilboum RM.
    Mayo Clin Proc; 1980 Jun 03; 55(6):390-402. PubMed ID: 6103981
    [Abstract] [Full Text] [Related]

  • 28. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
    Baum T, Shropshire AT, Varner LL.
    J Pharmacol Exp Ther; 1972 Jul 03; 182(1):135-44. PubMed ID: 5041650
    [No Abstract] [Full Text] [Related]

  • 29. [Adrenergic mechanisms of antidepressant action].
    Mashkovskiĭ MD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May 03; 70(5):750-9. PubMed ID: 4916171
    [No Abstract] [Full Text] [Related]

  • 30. [On hemodynamic aspects of antihypertensive therapy. Behavior of musculocutaneous and hepatosplanchnic circulation].
    Campus S, Accatino G.
    Minerva Med; 1965 Oct 17; 56(83):3517-9. PubMed ID: 4378780
    [No Abstract] [Full Text] [Related]

  • 31. [Critical considerations on the method of action of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride].
    Graubner W, Wolf M.
    Arzneimittelforschung; 1966 Aug 17; 16(8):1055-8. PubMed ID: 6014889
    [No Abstract] [Full Text] [Related]

  • 32. TOXICITY OF HYPOTENSIVE DRUGS.
    WILSON GM.
    Practitioner; 1965 Jan 17; 194():51-5. PubMed ID: 14259691
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of intraneuronal vesicles in the synthesis, storage, and release of catecholamines.
    Potter LT.
    Circ Res; 1967 Dec 17; 21(6):Suppl 3:13-24. PubMed ID: 4295533
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Influence of antihypertensive agents on catecholamine and metabolite excretion and its significance for the diagnosis of pheochromocytoma].
    Hengstmann JH, Dengler HJ.
    Dtsch Med Wochenschr; 1975 Nov 07; 100(45):2349-53. PubMed ID: 241624
    [No Abstract] [Full Text] [Related]

  • 39. Relationship between the roles of monoamine oxidase and sympathetic nerves in the vasoconstrictor response of the rabbit ear artery to norepinephrine.
    De la Lande IS, Jellett LB.
    J Pharmacol Exp Ther; 1972 Jan 07; 180(1):47-55. PubMed ID: 5010417
    [No Abstract] [Full Text] [Related]

  • 40. Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs.
    Prichard BN.
    Proc R Soc Med; 1969 Jan 07; 62(1):84-91. PubMed ID: 5763482
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.